FDA approves Novavax Covid vaccine after delay

Helen Branswell covers points broadly associated to infectious ailments, together with outbreaks, preparedness, analysis, and vaccine growth. Observe her on Mastodon and Bluesky. You possibly can attain Helen on Sign at hbranswell.01.

The Meals and Drug Administration has lastly accredited Novavax’s Covid-19 vaccine, however in doing so has positioned restrictions on it that its two opponents within the U.S. market don’t face.

The long-awaited license limits use of the vaccine to individuals 65 and older and other people aged 12 to 64 who’ve not less than one medical situation that places them at larger danger of extreme sickness in the event that they contract Covid. The vaccine has been obtainable below an emergency use authorization.

The FDA missed an April 1 deadline to rule on Novavax’s software. It was reported that political appointees in Commissioner Marty Makary’s workplace overrode profession workers, who advisable issuing the license. Novavax’s inventory value is down 21% because the begin of the 12 months.